AIM
Alambic Investment Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,323
| Closed | -$267K | – | 10 |
|
|
2020
Q3 | $267K | Sell |
15,323
-14,524
| -49% | -$253K | 2.93% | 10 |
|
|
2020
Q2 | $502K | Buy |
29,847
+300
| +1% | +$5.05K | 1.26% | 14 |
|
|
2020
Q1 | $351K | Sell |
29,547
-12,926
| -30% | -$154K | 0.85% | 39 |
|
|
2019
Q4 | $514K | Buy |
+42,473
| New | +$514K | 0.43% | 85 |
|
|
2019
Q2 | – | Sell |
-28,500
| Closed | -$335K | – | 314 |
|
|
2019
Q1 | $335K | Buy |
+28,500
| New | +$335K | 0.14% | 215 |
|
|
2017
Q2 | – | Sell |
-18,800
| Closed | -$206K | – | 583 |
|
|
2017
Q1 | $206K | Sell |
18,800
-5,200
| -22% | -$57K | 0.03% | 570 |
|
|
2016
Q4 | $174K | Sell |
24,000
-4,300
| -15% | -$31.2K | 0.03% | 513 |
|
|
2016
Q3 | $184K | Buy |
28,300
+11,400
| +67% | +$74.1K | 0.04% | 438 |
|
|
2016
Q2 | $92K | Buy |
+16,900
| New | +$92K | 0.02% | 498 |
|